Words by Jade Williams
05 August
Sanofi and Innovent Biologics partner to expand access to innovative medicines for hard-to-treat cancers in China
11 August
Medicines Discovery Catapult and Zeiss collaborate to drive microscopy use in drug discovery
23 August
Roche launches PCR system with potential to find and quantify ultra-rare, hard-to-detect disease mutations
24 August
AbbVie and J&J’s drug Imbruvica for chronic graft-versus-host disease gains first paediatric approval from FDA
30 August
Neurocrine Biosciences acquires UK biotech Diurnal Group for £48.3m
06 September
WHO grants prequalification to GSK’s Mosquirix – the first and only approved malaria vaccine
07 September
Almylyx’s drug to slow ALS progression receives FDA recommendation after rejection in March
13 September
Merck Foundation launches $20m, five-year initiative to address inequities in cancer care in the US
21 September
GSK and Microsoft launch disease surveillance project in Nepal to tackle climate-based disease transmission
26 September
Moderna joins the UK Bioindustry Association as its 500th member
28 September
Eisai and Biogen’s lecanemab first Alzheimer’s drug to meet primary endpoints in Phase 3 trial
03 October
FDA approves Kite Pharma’s retroviral vector manufacturing facility in California for commercial production
This news round up will feature in GOLD 24 – subscribe now to read the full issue when it's published on 25 October.